| Ytd | 17.16% | |
| 1y | -1.62% |
| Open | 27.13 | Prev Close | 26.80 | Low | 26.42 | High | 27.59 | Mkt Cap | 2.65B |
| Vol | 614.51K | Avg Vol | 2.24M | EPS | -5.84 | P/E | -4.62 | Forward P/E | 8.12 |
| Beta | 0.35 | Short Ratio | 4.24 | Inst. Own | 110.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 27.69 | 200-d Avg | 26.78 | 1yr Est | 52.84 |
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE - Get Free Report)'s share price gapped up before the m
RARE beats Q2 earnings estimates as revenues surge year over year to a record quarterly high, driven
Ultragenyx Pharmaceutical Inc. (RARE) Q2 2026 Earnings Call Transcript
Ultragenyx Pharmaceutical NASDAQ: RARE reported second-quarter 2026 revenue of $214 million, led by
While the top- and bottom-line numbers for Ultragenyx (RARE) give a sense of how the business perfor
Ultragenyx (RARE) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estima
Second quarter total revenue of $214 million, Crysvita® revenue of $156 million and Dojolvi® revenu
NOVATO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a b
Ultragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earn
Entropy Technologies LP grew its position in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) by 80.9%
NOVATO, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a b
SYDNEY, July 23, 2026 (GLOBE NEWSWIRE) -- Brazilian Rare Earths Limited (ASX: BRE / OTCQX: BRELY) ('
Fifth Third Bancorp bought a new stake in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) during the f
LEADING EDGE MATERIALS ADVANCES MIDSTREAM PROCESSING STRATEGY FOR THE NORRA KÄRR HEAVY RARE EARTH EL
SAN DIEGO, July 15, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims
NOVATO, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) rele
Ultragenyx (RARE) saw its shares surge in the last session with trading volume being higher than ave
Ultragenyx (RARE) is transitioning from a broad pipeline to a focused rare disease platform, enterin
NOVATO, Calif. , June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a
U.S. stocks traded higher by midday Wednesday, with semiconductor equipment names and small caps lea
U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% a
Benzinga examined the prospects for many investors' favorite stocks over the last week — here
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly ear
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fisc
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for i
On Monday, 413 companies reached new 52-week lows.
On Tuesday, 838 companies hit new 52-week lows.
During Monday's trading, 528 companies set new 52-week lows.
On Friday, 404 stocks made new 52-week lows.
Monday saw 825 companies set new 52-week lows.
On Thursday, 1076 companies hit new 52-week lows.